Take the pledge to vote

For a better tommorow#AajSawaroApnaKal
  • I agree to receive emails from News18

  • I promise to vote in this year's elections no matter what the odds are.
  • Please check above checkbox.


Thank you for
taking the pledge

Vote responsibly as each vote counts
and makes a diffrence


Issued in public interest by HDFC Life. HDFC Life Insurance Company Limited (Formerly HDFC Standard Life Insurance Company Limited) (“HDFC Life”). CIN: L65110MH2000PLC128245, IRDAI Reg. No. 101 . The name/letters "HDFC" in the name/logo of the company belongs to Housing Development Finance Corporation Limited ("HDFC Limited") and is used by HDFC Life under an agreement entered into with HDFC Limited. ARN EU/04/19/13618
LIVE TV DownloadNews18 App
News18 English

Alzheimer's Drug Effective if Used Before Symptoms Develop

The drug "memantine" might have potent disease-modifying properties if administered long before people become symptomatic and diagnosed with Alzheimer's disease.


Updated:August 3, 2018, 6:22 PM IST
Alzheimer's Drug Effective if Used Before Symptoms Develop
Image for representational purpose only. (Photo courtesy: AFP Relaxnews/ Dmitry Berkut / Istock.com)

New York: A US FDA-approved drug, used to treat moderate to severe Alzheimer's disease, if taken before symptoms appear, might prevent or slow the progression of the neurogenerative disease, researchers say.

The experiments suggest that the drug "memantine" might have potent disease-modifying properties if administered long before people become symptomatic and diagnosed with Alzheimer's disease.

"Perhaps this could prevent the disease or slow its progression long enough than the average age of symptom onset, if it happens at all," said George Bloom, Professor at the University of Virginia in the US.

As Alzheimer's begins, there is a lengthy period of time, perhaps a decade or longer, when brain neurons affected by the disease attempt to divide, possibly as a way to compensate for the death of neurons.

This is unusual in that most neurons develop prenatally and then never divide again. But in Alzheimer's the cells make the attempt and then die.

"It's been estimated that as much as 90 per cent of neuron death that occurs in the Alzheimer's brain follows this cell cycle re-entry process, which is an abnormal attempt to divide," Bloom said, in the paper published in the journal Alzheimer's & Dementia.

"By the end of the course of the disease, the patient will have lost about 30 per cent of the neurons in the frontal lobes of the brain."

The team found that when neurons are exposed to toxic protein amyloid oligomers, the channel called the NMDA receptor opens, thus allowing the calcium flow that drives neurons back into the cell cycle.

Memantine blocks cell cycle re-entry by closing the NMDA receptor, the research confirmed.

Side effects of the drug appear to be infrequent and modest.

"I don't want to raise false hopes," Bloom said, but "if this idea of using memantine as a prophylactic pans out, it will be because we now understand that calcium is one of the agents that gets the disease started, and we may be able to stop or slow the process if done very early."

Get the best of News18 delivered to your inbox - subscribe to News18 Daybreak. Follow News18.com on Twitter, Instagram, Facebook, TikTok and on YouTube, and stay in the know with what's happening in the world around you – in real time.

Subscribe to Moneycontrol Pro and gain access to curated markets data, trading recommendations, equity analysis, investment ideas, insights from market gurus and much more. Get Moneycontrol PRO for 1 year at price of 3 months. Use code FREEDOM.

| Edited by: Manila Venugopal
Read full article
Next Story
Next Story

Also Watch


Live TV

Countdown To Elections Results
To Assembly Elections 2018 Results